These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 25835481)
1. Landscape of current and emerging cell therapy clinical trials in the UK: current status, comparison to global trends and future perspectives. Bisson I; Green E; Sharpe M; Herbert C; Hyllner J; Mount N Regen Med; 2015; 10(2):169-79. PubMed ID: 25835481 [TBL] [Abstract][Full Text] [Related]
2. The Cell Therapy Catapult: growing a U.K. cell therapy industry generating health and wealth. Thompson K; Foster EP Stem Cells Dev; 2013 Dec; 22 Suppl 1():35-9. PubMed ID: 24304073 [TBL] [Abstract][Full Text] [Related]
3. Transplantation for stroke. Roitberg B Neurol Res; 2004 Apr; 26(3):256-64. PubMed ID: 15142317 [TBL] [Abstract][Full Text] [Related]
4. New guidance on codes of practice, standardized methods and regulations for cell-based therapeutics. Harris N; Munro C; Patel B Regen Med; 2006 Sep; 1(5):705-7. PubMed ID: 17465738 [TBL] [Abstract][Full Text] [Related]
12. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada. Roy DC; Alarco AM; Isasi R Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957 [TBL] [Abstract][Full Text] [Related]
13. Potential benefits of cell therapy in coronary heart disease. Grimaldi V; Mancini FP; Casamassimi A; Al-Omran M; Zullo A; Infante T; Napoli C J Cardiol; 2013 Nov; 62(5):267-76. PubMed ID: 23834957 [TBL] [Abstract][Full Text] [Related]
14. The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer. Henick BS; Herbst RS; Goldberg SB Expert Opin Ther Targets; 2014 Dec; 18(12):1407-20. PubMed ID: 25331677 [TBL] [Abstract][Full Text] [Related]
15. The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK. Hearn J; Sullivan R Eur J Cancer; 2007 Jan; 43(1):8-13. PubMed ID: 17118647 [TBL] [Abstract][Full Text] [Related]
16. The impact of registration of clinical trials units: the UK experience. McFadden E; Bashir S; Canham S; Darbyshire J; Davidson P; Day S; Emery S; Pater J; Rudkin S; Stead M; Brown J Clin Trials; 2015 Apr; 12(2):166-73. PubMed ID: 25475881 [TBL] [Abstract][Full Text] [Related]
17. Organizational profile: UK regenerative medicine platform immunomodulation hub. Asante CO Regen Med; 2015; 10(3):259-63. PubMed ID: 25933235 [TBL] [Abstract][Full Text] [Related]
18. Current status and future perspectives of dendritic cell-based cancer immunotherapy. H Yi D; Appel S Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402 [TBL] [Abstract][Full Text] [Related]
19. Design of clinical trials for therapeutic cancer vaccines development. Mackiewicz J; Mackiewicz A Eur J Pharmacol; 2009 Dec; 625(1-3):84-9. PubMed ID: 19835869 [TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]